MLYS Mineralys Therapeutics
- 12.410
- -0.160-1.27%
- 12.410
- 0.0000.00%
Mineralys Therapeutics News
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | 10-Q: Q2 2024 Earnings Report
Mineralys Therapeutics | 8-K: Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Slingsby Brian Taylor
Mineralys Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Levy Adam Scott
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Congleton Jon
Mineralys Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mineralys Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Congleton Jon
Mineralys Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mineralys Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mineralys Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mineralys Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Gold Alexander M
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gold Alexander M
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Congleton Jon
Mineralys Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
